DK167020B1 - Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner - Google Patents

Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner Download PDF

Info

Publication number
DK167020B1
DK167020B1 DK611689A DK611689A DK167020B1 DK 167020 B1 DK167020 B1 DK 167020B1 DK 611689 A DK611689 A DK 611689A DK 611689 A DK611689 A DK 611689A DK 167020 B1 DK167020 B1 DK 167020B1
Authority
DK
Denmark
Prior art keywords
group
carbon atoms
process according
alkoxy
groups
Prior art date
Application number
DK611689A
Other languages
Danish (da)
English (en)
Other versions
DK611689A (da
DK611689D0 (da
Inventor
Marc Bonato
Charles Eck
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of DK611689A publication Critical patent/DK611689A/da
Publication of DK611689D0 publication Critical patent/DK611689D0/da
Application granted granted Critical
Publication of DK167020B1 publication Critical patent/DK167020B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DK611689A 1988-04-06 1989-12-05 Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner DK167020B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8808001 1988-04-06
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives
FR8900157 1989-01-09
PCT/FR1989/000157 WO1989009772A1 (fr) 1988-04-06 1989-04-06 PROCEDE STEREOSPECIFIQUE POUR LA PREPARATION DES ENANTIOMERES DE LA FURO[3,4-c]PYRIDINE, COMPOSES AINSI OBTENUS ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES COMPOSES

Publications (3)

Publication Number Publication Date
DK611689A DK611689A (da) 1989-12-05
DK611689D0 DK611689D0 (da) 1989-12-05
DK167020B1 true DK167020B1 (da) 1993-08-16

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK611689A DK167020B1 (da) 1988-04-06 1989-12-05 Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner

Country Status (28)

Country Link
US (1) US5026855A (pt)
EP (1) EP0337858B1 (pt)
JP (1) JP2680456B2 (pt)
KR (1) KR970005308B1 (pt)
AT (1) AT397093B (pt)
AU (1) AU616753B2 (pt)
BE (1) BE1003843A4 (pt)
CA (1) CA1338475C (pt)
CH (1) CH680000A5 (pt)
DK (1) DK167020B1 (pt)
DZ (1) DZ1335A1 (pt)
ES (1) ES2057159T3 (pt)
FI (1) FI93116C (pt)
FR (2) FR2629821B1 (pt)
GB (2) GB8808001D0 (pt)
IE (1) IE61915B1 (pt)
IN (1) IN172987B (pt)
MA (1) MA21529A1 (pt)
MY (1) MY104424A (pt)
NL (1) NL8920307A (pt)
NZ (1) NZ228614A (pt)
OA (1) OA09247A (pt)
PT (1) PT90210B (pt)
SE (1) SE509130C2 (pt)
SG (1) SG40492G (pt)
TN (1) TNSN89043A1 (pt)
WO (1) WO1989009772A1 (pt)
ZA (1) ZA892477B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ. コルネット, 肺疾患および心疾患の処置におけるシクレタニンおよびpkc阻害剤
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (pt) * 1981-02-10 1985-11-09 Scras
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (pt) * 1983-04-05 1987-06-27 Scras
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
AU3419089A (en) 1989-11-03
PT90210A (pt) 1989-11-10
GB8808001D0 (en) 1988-05-05
FI93116B (fi) 1994-11-15
CH680000A5 (pt) 1992-05-29
BE1003843A4 (fr) 1992-06-30
SE8904104L (sv) 1989-12-05
IE891076L (en) 1989-10-06
EP0337858B1 (fr) 1994-06-08
NL8920307A (nl) 1990-03-01
FI93116C (fi) 1995-02-27
FI895826A0 (fi) 1989-12-05
FR2629820A1 (fr) 1989-10-13
DZ1335A1 (fr) 2004-09-13
JPH02504394A (ja) 1990-12-13
ES2057159T3 (es) 1994-10-16
SG40492G (en) 1992-06-12
JP2680456B2 (ja) 1997-11-19
MA21529A1 (fr) 1989-12-31
KR970005308B1 (ko) 1997-04-15
FR2629820B1 (fr) 1993-12-03
AT397093B (de) 1994-01-25
GB2235194B (en) 1992-01-29
GB8927509D0 (en) 1990-06-13
WO1989009772A1 (fr) 1989-10-19
EP0337858A1 (fr) 1989-10-18
SE509130C2 (sv) 1998-12-07
ATA900589A (de) 1993-06-15
OA09247A (fr) 1992-06-30
IE61915B1 (en) 1994-11-30
US5026855A (en) 1991-06-25
KR900700483A (ko) 1990-08-13
SE8904104D0 (sv) 1989-12-05
FR2629821A1 (fr) 1989-10-13
MY104424A (en) 1994-03-31
FR2629821B1 (fr) 1993-12-03
ZA892477B (en) 1989-12-27
CA1338475C (en) 1996-07-23
NZ228614A (en) 1990-11-27
GB2235194A (en) 1991-02-27
IN172987B (pt) 1994-01-15
AU616753B2 (en) 1991-11-07
DK611689A (da) 1989-12-05
PT90210B (pt) 1994-06-30
DK611689D0 (da) 1989-12-05
TNSN89043A1 (fr) 1991-02-04

Similar Documents

Publication Publication Date Title
DK167020B1 (da) Stereospecifik fremgangsmaade til fremstilling af enantiomere af 3-substituerede furo(3,4-c)pyridiner
Hua et al. Stereoselective additions of chiral. alpha.-sulfinyl ketimine anions to ene esters. Asymmetric syntheses of indolo [2, 3-a] quinolizidine and yohimban alkaloids
KR20000068135A (ko) 지방친화성이 높은 캠프토테신 유도체
SE430983B (sv) Farmaceutiskt aktiva derivat av 1-hydroxi-oktahydrofenantren-9-on, 1,9-dihydroxi-oktahydrofenantren och 1-hydroxi-hexa-hydrofenantren-9-on
CA1300626C (en) Dihydropyridine compounds, processes for their preparation and their use
CA1051899A (en) Vincamine compounds
KR19990087110A (ko) 캄토테신 유도체와 이를 활성 성분으로 하는 항암제
US6258829B1 (en) Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
Lindgren et al. Synthesis of anatoxin-a, a constituent of blue-green freshwater algae
JP2001151776A (ja) 新規カンプトテシン類似化合物、それらの製造方法、及びそれらを含有する医薬組成物
US4081449A (en) Heterocyclic esters of alkylphenyl benzopyranopyridines
CA1293508C (en) Dihydropyridinelactols, processes for their preparation and their use as medicaments
US4168379A (en) Pyridin-3-ols
NO172390B (no) Analogifremgangsmaate for stereospesifikk fremstilling av terapeutisk aktive furo(3,4-c)-pyridin-enantiomerer
EP0019254B1 (en) 7-methyl and 7-methyl-8-lower alkyl b/c cis or trans morphinan-6-one compounds, process for their preparation and pharmaceutical preparations containing them
Riechers et al. Cyclization of 3‐Aminoacrylates–Total Synthesis of Pumiliotoxin C and Related Stereoisomeric Compounds
CS273602B2 (en) Method of azabicyclo-/3,3,1/ nonane's new derivatives preparation
JPH07179461A (ja) 12−ヘテロ置換6,11−エタノ−6,11−ジヒドロベンゾ〔b〕キノリジニウム塩類、それらの組成物および製造方法
KR840000150B1 (ko) 스피로[디벤즈(b, f)옥세핀-피페리딘]의 제조방법
EP0039091B1 (en) Spirobenzofuranone compounds
GB1583554A (en) Quaternary derivatives of sandwicin and a method of producing them
IE46003B1 (en) 3-phenoxy-n-substituted morphinan derivatives, their manufacture and pharmaceutical preparations containing them
AU2003301531A1 (en) Substituted benzol(e) (1,4) oxazino(3,2-g) isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
HU186416B (hu) KljárÓB Hpiro—berizofu Kíinori — szár inazökok előállítására

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK